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LEVATED ICP has been recognized as one of the most
important factors affecting morbidity and mortality
rates in patients who have suffered TBI;23,24,34 there-
fore, ICP monitoring has become routine in the manage-
ment of severe head injuries in both adults and children. A
variety of monitoring techniques and devices are avail-
able, each with advantages and disadvantages. An EVD is
considered the gold standard for accurate ICP monitoring,
and it allows for drainage of CSF, a potentially important
means to lower elevated pressures.15,25 Alternatively, sev-
eral different types of fiberoptic monitoring systems are
currently available that can be placed in the epidural
space, subdural space, brain parenchyma, or ventricle.4,5,
13,16,17,30–34,39,41
Overall, insertion of an ICP monitor is thought to be a
safe and effective adjunct in the management of raised
ICP, producing a low incidence of hemorrhagic or infec-
tious complications.1,2,4,5,13,16,17,20,22,26,30–34,39,41 Authors of the
majority of studies have focused on adult patients in
whom ICP monitors have been placed for a variety of rea-
sons, including head trauma, metabolic coma, hydro-
cephalus, and postoperative craniotomy. There are few
studies in the literature in which these issues are addressed
in the pediatric population.5,16,33
Authors of a recently published report described the
hemorrhagic complications of fiberoptic intraparenchy-
mal monitors in children.5 When monitoring ICP, howev-
er, many surgeons prefer to use EVDs alone or concomi-
tant with fiberoptic devices when possible because of the
added benefit of drainage of CSF to reduce elevated ICP.
Although the complication rates associated with EVDs
have been examined in detail in previous reports,11,18,
20,27,28,41 none has addressed exclusively the complication
rates in children who have suffered head trauma. Because
of the generally smaller ventricle size and thin scalps in
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Object. Intracranial pressure (ICP) monitoring has become routine in the management of patients with traumatic
brain injury (TBI). Many surgeons prefer to use external ventricular drains (EVDs) over fiberoptic monitors to mea-
sure ICP because of the added benefit of cerebrospinal fluid drainage. The purpose of this study was to examine a con-
secutive series of children with TBI and compare the incidence of complications after placement of an EVD, a fiberop-
tic intraparencyhmal monitor, or both.
Methods. A retrospective chart review was conducted to identify children with TBI who met the criteria for insertion
of an ICP monitor. All patients underwent head CT scanning on admission and after placement of an ICP monitor. 
During a 5-year period 80 children met the criteria for inclusion in the study. Eighteen children (22.5%) underwent
EVD placement only, 18 (22.5%) underwent placement of a fiberoptic device only, and 44 (55%) received both. A
total of 62 fiberoptic devices (48%) were inserted, and 68 EVDs (52%) were placed. Overall, there was a fourfold
increased risk of complications in children who received an EVD compared with those in whom a fiberoptic monitor
was placed (p = 0.004). Hemorrhagic complications were detected in 12 (17.6%) of 62 patients who received an EVD
compared with four (6.5%) of 62 patients who received a fiberoptic monitor (p = 0.025). Six (8.8%) of 68 EVDs were
malpositioned and required replacement; in three (50%) of these cases a hemorrhagic complication occurred. Only one
infection was noted in a patient with an EVD (1.5%).
Conclusions. In this retrospective cohort of pediatric patients with TBI, complication rates were significantly high-
er in those receiving EVDs than in those in whom fiberoptic monitors were placed. Although the majority of these
complications did not entail clinical sequelae, surgeons should be aware of the different complication rates when
choosing the most appropriate device for each patient.
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Abbreviations used in this paper: CT = computerized tomogra-
phy; CSF = cerebrospinal fuid; EVD = external venticular drain;
ICP = intracranial pressure.
children, it is certainly possible that both the hemorrhagic
and infection complication rates in this group of patients
may differ substantially from those reported previously.
The purpose of this study was to examine a consecutive
series of children with TBI in whom an ICP monitor had
been placed and to compare the incidence of complica-
tions (hemorrhagic, infectious, and malpositioning) after
insertion of an EVD, a fiberoptic intraparenchymal ICP
monitor, or both. 
Clinical Material and Methods
Patient Population
Between 1998 and 2003, a total of 80 children admitted
to Primary Children’s Medical Center after sustaining
head trauma were evaluated and met criteria for insertion
of an ICP monitoring device (EVD, intraparenchymal
fiberoptic monitor, or both). The mean age of this group
was 8.5 years (range 0.5–18 years). There were 51 boys
(64%) and 29 girls (36%). Criteria for ICP monitoring
were standardized and included children with an initial
Glasgow Coma Scale score of less than 8, with evidence
of intracranial injury or elevated ICP (such as, effacement
of cisterns) on head CT scans.15,19 Prior to placement of
either an EVD or fiberoptic ICP monitor, the results of
normal coagulation studies and platelet levels were con-
firmed. Children who had undergone placement of an ICP
monitoring device after elective intracranial procedures or
for the treatment of hydrocephalus were excluded from
this study. 
Study Methodology
A retrospective review of patients’ hospital charts, lab-
oratory studies, and radiographic studies was conducted.
Head CT scans obtained at admission and after placement
of an ICP monitoring device were available in all patients
included in the study. Unless unusual circumstances arose,
postprocedure CT scans were obtained within 24 hours
(maximum 5 days after insertion). All CT scans were rev-
iewed and graded by the authors based on a previously
published scale.5
ICP Monitoring Devices
Patients who underwent placement of a fiberoptic intra-
parenchymal monitor (Camino; Integra LifeSciences,
Plainsboro, NJ), an EVD, or both were included in this
study. Monitoring devices in all patients were placed at the
bedside in the pediatric intensive care unit after normal
results of coagulation and platelet studies were confirmed.
The decision to use the right or left side was based primar-
ily on the location of intracranial injury, skull fracture, and
skin covering; in ambivalent situations, the right side was
preferred. The insertion point for all monitoring devices
was approximately 1 cm anterior to the coronal suture in
the midpupillary line. The area of interest was shaved and
aseptically draped, and local anesthetic was infiltrated. A
stab incision was made through the skin down to the bone.
A twist-drill hole was then made through the skull, and the
dura was pierced with an 18-gauge spinal needle. If a
fiberoptic device was placed, the Camino bolt was screwed
manually into the bone and the catheter was connected to a
monitor, calibrated to zero, and then placed through the bolt
approximately 2 cm into the brain parenchyma. If an EVD
was placed, the catheter was directed using anatomical
landmarks into the frontal horn of the lateral ventricle, tun-
neled subcutaneously to a distant site, and secured to the
skin by using 2-0 silk ties. No more than three attempts
were made to cannulate the ventricle. The catheter was
connected to an external drainage bag and left open at 10 to
15 cm H2O above the ear. If a second monitor was used
concomitantly, it was placed through a separate incision
just anterior to the first monitor. Personal preferences of the
senior authors (J.R.W.K., D.L.B., M.L.W.) determined
which monitor type was used or whether dual monitoring
was used. Monitoring was discontinued when ICP and
waveforms returned to normal after the patient was suc-
cessfully weaned from ICP lowering maneuvers. 
Outcome Criteria
Intracranial hemorrhage attributable to the placement of
the monitoring device was defined as a new area of hem-
orrhage adjacent to the probe, which could be demonstrat-
ed on a postprocedure head CT scan. In all cases of dual
monitoring, the location of the hemorrhage made it possi-
ble to determine which monitoring device was responsible
for the hemorrhage. Malpositioned EVDs were defined as
those catheters shown on a CT scan to be outside the ven-
tricular system and which required a second procedure for
replacement of the device. External ventricular drains that
were found in locations other than the frontal horn on
postprocedure CT scanning (third ventricle, contralateral
lateral ventricle) but that continued to drain CSF were not
considered complications. Meningitis and ventriculitis
were diagnosed from positive CSF cultures. No prophy-
lactic antibiotic agents were administered during the ICP
monitoring. Cerebrospinal fluid was cultured only when a
fever was present, because routine analysis of CSF in chil-
dren with EVDs is not supported by the literature.14
Results
Among children consecutively evaluated over a 5-year
period at a Level 1 trauma and regional medical center, ICP
monitoring was performed in 80 patients. More than one
procedure was performed in 50 children for a total of 130
procedures. Eighteen children (22.5%) underwent place-
ment of an EVD only, 18 (22.5%) received a fiberoptic
intraparenchymal device only, and 44 (55%) underwent
placement of both. In six patients, it was necessary to place
a second EVD; therefore, a total of 62 fiberoptic devices
(48%) were implanted and 68 EVDs (52%) were placed. 
Hemorrhagic Complications
A total of 114 procedures (87.7%) were performed with-
out any hemorrhagic complications. To facilitate compar-
isons, we classified hemorrhages according to the grading
system recently proposed by Blaha and colleagues.5 Grade
I hemorrhages are small punctate hemorrhages or localized
subarachnoid hemorrhages; Grade II hemorrhages are larg-
er bleeds that do not cause a new neurological deficit or
require surgical evacuation, but may alter readings of ICP;
and Grade III hemorrhages cause a new deficit or necessi-
tate surgical removal (Fig. 1). 
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Twelve (17.6%) of 68 EVD insertions led to hemorrhag-
ic complications detected on postprocedure CT scans: three
(25%) of these were Grade I, eight (67%) were Grade II,
and one (8%) was Grade III. In comparison, four (6.5%) of
62 patients who received fiberoptic intraparenchymal mon-
itors had hemorrhagic complications: three (75%) of these
were Grade I; one (25%) was Grade II; and none was
Grade III (Table 1). The difference in the incidence of hem-
orrhagic complications resulting from placement of EVDs
and intraparenchymal fiberoptic monitors reached statisti-
cal significance (p = 0.025). There was no difference in the
incidence of hemorrhage in patients receiving EVDs only
and those receiving both a fiberoptic intraparenchymal
monitor and an EVD (p = 0.79).
Infection Complications
There were no complications due to infection in the 62
patients receiving fiberoptic intraparenchymal monitors.
One (1.6%) of 62 patients in whom an EVD was placed
suffered an infection complication. An EVD was removed
from this patient after 9 days, and cultures grew Staphlo-
coccus aureus. 
Malpositioned Catheters and Mechanical Failure
Six (8.8%) of 68 EVD insertions resulted in malposi-
tions and replacement was required (Fig. 2). Of note, three
(50%) of these reinsertions resulted in hemorrhagic com-
plications. None of the fiberoptic monitors had to be
replaced because of mechanical failure.
Discussion
Given all of the clinical indications for its use, ICP
monitoring has had the most positive impact on the man-
agement of severe TBI.19 Abnormal elevations of ICP
commonly occur in patients with TBI, and numerous stud-
ies show that control of ICP improves outcome.3,10,21,27,35
Although ICP monitoring has become routine, there are
no guidelines regarding whether to use an intraparenchy-
mal fiberoptic monitor or an EVD when monitoring is
desired after TBI. The device selected is at present dictat-
ed primarily by the surgeon’s personal preference.
Both types of monitors have advantages and disadvan-
tages. Many surgeons prefer the EVD because it is con-
sidered the gold standard, and problems with its operation
are easy to troubleshoot. Use of the ventricular catheter
has the added advantage of allowing the therapeutic
drainage of CSF to lower ICP.16,27 This device also requires
that the brain be fully penetrated; requires some skill in
placement, especially in the case of small of shifted ven-
tricles; can malfunction or dampen secondary to air locks
and debris; and its placement produces a small but definite
risk of infection. The advantage of the fiberoptic monitor-
ing device system is ease of placement; that is, it allows
direct measurement of brain tissue pressure in patients
with compressed or dislocated ventricles in which place-
ment of EVDs would be difficult,12,16 which is especially
important in children, because ventricle size is small un-
less the child has hydrocephalus.9 Disadvantages of the
device include fragility, mechanical failure, higher com-
plexity and expense, and incompatibility with magnetic
resonance units. In addition it is not possible to recalibrate
this device in situ if the monitor becomes subject to drift
or dampening of waveforms.7,12,29,40 Accidental displace-
ment, fracture, or monitor malfunction requiring replace-
ment has been reported in up to 13% of patients.16,32,33
Several studies in adults have demonstrated that the
complications of ICP monitoring are at least in part depen-
dent on the type of monitor used.13,17,34 Because EVDs are
larger than the fiberoptic intraparenchymal monitors,
require the brain to be completely penetrated, and may
require multiple passes through the brain, it is not surpris-
ing that the highest reported hemorrhagic complication
rates occur when placing EVDs. The reported risk of hem-
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FIG. 1. Axial unenhanced head CT scans demonstrating Grades
I (A), II (B), and III (C) hemorrhages.
TABLE 1
Comparison of hemorrhagic complication rates in patients with
EVDs and intraparenchymal fiberoptic monitor*
Hemorrhage Grade (%)
Type of No. of
Monitor Patients I II III Total
EVD 68 3 (4.4) 8 (11.7) 1 (1.5) 12 (17.6)
fiberoptic 62 3 (4.8) 1 (1.6) 0 4 (6.4)
orrhage produced by EVDs is between 2 and 10%.11,27,28,41
Our hemorrhagic complication rate of 17.6% is substan-
tially higher than those previously reported. There are at
least two possible explanations for this difference. First,
standardized evaluation of CT scans obtained after EVD
insertion was not performed in most earlier studies,41 so
small hemorrhages likely went undetected. Second, previ-
ous studies have included primarily adult patients or chil-
dren with hydrocephalus, both of whom are likely to have
substantially larger ventricles than children after TBI. We
do not think that unusual technical issues are responsible
for the increased hemorrhagic rate seen after EVD inser-
tion. No more than three passes were performed to attempt
ventricular cannulation. Furthermore, if any of our tech-
niques in drilling or dural penetration were responsible for
an increased hemorrhage rate after EVD insertion, we
would also expect a higher rate of hemorrhage after fi-
beroptic monitor insertion, which we did not find (6.4%).
Because normal coagulation studies and platelet levels
were required before EVD placement, we do not think that
unusual coagulopathies are responsible for the increased
hemorrhagic rate seen after EVD insertion. 
We and other authors recognize that the high hemor-
rhagic complication rates associated with these intraven-
tricular monitors are in most cases radiographic findings
without clinical significance.17,22 Although this is certainly
true, it can often be difficult to evaluate the clinical impor-
tance of hemorrhages in children after TBI because they
are often paralyzed and sedated as an early measure to
reduce elevated ICP. These children may require addition-
al diagnostic studies to monitor their evolution and thera-
peutic intervention to replace the monitoring device.
Paralysis and sedation may cause a false reading of ICP. 
The reported incidences of hemorrhagic complications
from intraparenchymal monitors ranges from 0 to 10%.4,6,8,
13,16,22,26,33,37,42,43 The three previously published studies in
which only children were included reported hemorrhagic
complications of 0, 0.3, and 9.7%.5,16,33 Our hemorrhage
rate of 6.4% is similar to prior reports.
In our series, there was only one infection (1.6%) in a
12-year-old child in whom an EVD had been placed for 9
days. The low infection rate was rather surprising because
we hypothesized that children with thinner scalps in the
setting of high ICP would have an increased risk for CSF
leak and infection. The reported range of infection rate for
EVDs varies from 0 to 45%, with authors of most large
series and reviews indicating that the risk of infection is
approximately 10%.18,20 We did not prophylactically
change EVDs or administer antibiotic agents because the
risk of infection does not appear to be reduced by these
measures.18 We did not detect any infections in children in
whom fiberoptic ICP monitors had been placed. These
results are in agreement with prior reports that fiberoptic
intraparenchymal monitoring is associated with a very
low infection rate.33,38,43
There was an 8.8% rate (six of 68) of malpositioned
EVDs in our series. Although we expected this complica-
tion rate to be higher in this population because of the
smaller ventricles in children, our results are within the
1.5 to 20% rates of catheter malpositioning that have been
reported previously.13,17,30 The wide range of complication
rates is likely due to varying criteria for a “malpositioned
catheter,” which have been described as anything from a
functioning catheter with its tip in the third ventricle to a
nonfunctional catheter requiring replacement. 
The largest group of patients in our study underwent
dual monitoring. We did not find any difference in the risk
of complications when comparing children who received
both an EVD and a fiberoptic monitor with those receiv-
ing only an EVD (p = 0.79). Some authors have advocat-
ed the use of two monitors at the same time because dual
monitoring allows simultaneous therapeutic drainage of
CSF through the ventricular catheter and moment-to-
moment readings of ICP from the parenchymal moni-
tor.19,36 This dual method may become especially valuable
when ICP is elevated enough to cause collapse of the ven-
tricular system around a ventricular catheter, making
drainage of CSF at best intermittent and readings of ICP
from the catheter less reliable. Another clinical situation in
which dual monitoring may be helpful is when small ven-
tricle size precludes placement of a ventricular catheter at
the time therapy is initiated. Instead, a parenchymal mon-
itor can be inserted to begin aggressive medical manage-
ment. The parenchymal monitor may allow some expan-
sion of the ventricular system such that a safer or
successful cannulation of the ventricles can occur. In this
situation, the parenchymal monitor remains to guide ther-
apy, while the ventricular catheter becomes an avenue of
that therapy.19 Furthermore, the presence of two monitors
allows a crosscheck of the accuracy of either monitor
because differences in simultaneous recordings from
intraventricular pressures and intraparenchymal monitors
have been reported in some situations.36
In our retrospective cohort of pediatric patients who
sustained TBI, we found complication rates that were sig-
nificantly different depending on the type of monitor used.
Placement of an EVD was associated with a threefold in-
creased risk of hemorrhage when compared with place-
ment of a fiberoptic intraparenchymal monitor (p =
0.025). The nearly 10% rate of malpositioned catheters is
a complication unique to EVDs, with half of the malposi-
tioned catheters (three of six) leading to insertion of re-
placements that caused hemorrhages. Because of the small
number of infections in our group of patients (one or
1.6%), no conclusions can be drawn regarding the differ-
ence in risk of infection between an EVD or fiberoptic
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FIG. 2. Axial unenhanced head CT scan demonstrating a mal-
positioned EVD in the right thalamus that required reinsertion.
monitor. These rates must be interpreted with caution,
however, because they are raw, unadjusted measurements
of risk. Furthermore, it is important to note that the major-
ity of these complications did not cause clinical sequelae.
The retrospective nature of this study and the relatively
small number of patients are additional limitations of this
report. 
Conclusions
Although ICP monitoring has played an important role
in improving outcomes in patients with TBI, the proce-
dure is not without risk. We found an overall complication
rate of 28% for patients in whom EVDs had been placed
and 6.5% for those in whom a fiberoptic intraparenchymal
monitor was placed. There is no clear standard of care
regarding whether to use an intraparenchymal fiberoptic
monitor or an EVD when ICP monitoring is desired in
children with TBI. Because the complication rate associ-
ated with the use of an EVD is significantly higher than
that with the use of a fiberoptic intraparenchymal device
in children with TBI, it seems reasonable to consider a
fiberoptic device first unless there are compelling reasons
for immediate ventricular drainage. Although the majori-
ty of these complications were clinically insignificant,
surgeons should be aware of these different complication
rates when choosing the most appropriate device for each
patient.
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